Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Luna

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Medicine|February 1, 2018
Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization studySalvador Martín Algarra, Virtudes Soriano, Luis Fernández-Morales, et al.
Neuro-Oncology|July 1, 2024
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study)Iván Márquez-Rodas, Ana Álvarez, Ana Arance, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 24, 2022
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registryMaria Gonzalez-Cao, Teresa Puertolas, Clara Martinez-Vila, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Medicine|February 1, 2018
Dabrafenib plus trametinib for compassionate use in metastatic melanoma: A STROBE-compliant retrospective observational postauthorization studySalvador Martín Algarra, Virtudes Soriano, Luis Fernández-Morales, et al.
Neuro-Oncology|July 1, 2024
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study)Iván Márquez-Rodas, Ana Álvarez, Ana Arance, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 24, 2022
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registryMaria Gonzalez-Cao, Teresa Puertolas, Clara Martinez-Vila, et al.
Pageof 7